These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 24492893)

  • 1. Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?
    Callaghan R; Luk F; Bebawy M
    Drug Metab Dispos; 2014 Apr; 42(4):623-31. PubMed ID: 24492893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives.
    Binkhathlan Z; Lavasanifar A
    Curr Cancer Drug Targets; 2013 Mar; 13(3):326-46. PubMed ID: 23369096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
    Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
    Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological strategies for overcoming multidrug resistance.
    Nobili S; Landini I; Giglioni B; Mini E
    Curr Drug Targets; 2006 Jul; 7(7):861-79. PubMed ID: 16842217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.
    Ludwig JA; Szakács G; Martin SE; Chu BF; Cardarelli C; Sauna ZE; Caplen NJ; Fales HM; Ambudkar SV; Weinstein JN; Gottesman MM
    Cancer Res; 2006 May; 66(9):4808-15. PubMed ID: 16651436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based high-throughput screen identifies inhibitors that overcome P-glycoprotein (Pgp)-mediated multidrug resistance.
    Zahra R; Furqan M; Ullah R; Mithani A; Saleem RSZ; Faisal A
    PLoS One; 2020; 15(6):e0233993. PubMed ID: 32484843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery.
    Kou L; Sun R; Bhutia YD; Yao Q; Chen R
    Expert Opin Drug Deliv; 2018 Sep; 15(9):869-879. PubMed ID: 30169976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Heat Shock Protein 90 Inhibitors Suppress P-Glycoprotein Activity and Overcome Multidrug Resistance in Cancer Cells.
    Dinić J; Podolski-Renić A; Jovanović M; Musso L; Tsakovska I; Pajeva I; Dallavalle S; Pešić M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenulin and isotenulin inhibit P-glycoprotein function and overcome multidrug resistance in cancer cells.
    Chang YT; Wang CCN; Wang JY; Lee TE; Cheng YY; Morris-Natschke SL; Lee KH; Hung CC
    Phytomedicine; 2019 Feb; 53():252-262. PubMed ID: 30668405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
    Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
    Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy.
    Sachs J; Kadioglu O; Weber A; Mundorf V; Betz J; Efferth T; Pietruszka J; Teusch N
    J Nat Med; 2019 Jan; 73(1):226-235. PubMed ID: 30066239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.
    Patel A; Tiwari AK; Chufan EE; Sodani K; Anreddy N; Singh S; Ambudkar SV; Stephani R; Chen ZS
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):189-99. PubMed ID: 23673445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of Natural-Based Anticancer Compounds for P-Glycoprotein Inhibition.
    Dinić J; Podolski-Renić A; Jeremić M; Pešić M
    Curr Pharm Des; 2018; 24(36):4334-4354. PubMed ID: 30648503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update.
    Dong J; Qin Z; Zhang WD; Cheng G; Yehuda AG; Ashby CR; Chen ZS; Cheng XD; Qin JJ
    Drug Resist Updat; 2020 Mar; 49():100681. PubMed ID: 32014648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment.
    Waghray D; Zhang Q
    J Med Chem; 2018 Jun; 61(12):5108-5121. PubMed ID: 29251920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology.
    Xue X; Liang XJ
    Chin J Cancer; 2012 Feb; 31(2):100-9. PubMed ID: 22237039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P-glycoprotein--implications of metabolism of neoplastic cells and cancer therapy.
    Breier A; Barancík M; Sulová Z; Uhrík B
    Curr Cancer Drug Targets; 2005 Sep; 5(6):457-68. PubMed ID: 16178819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming multidrug resistance in human cancer cells by natural compounds.
    Nabekura T
    Toxins (Basel); 2010 Jun; 2(6):1207-24. PubMed ID: 22069634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
    Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
    Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.